A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)

NCT02732639 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis D, Chronic

Interventions

DRUG: Pegylated Interferon (PEG-IFN) alfa-2a

Sponsor

Hoffmann-La Roche